+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Phage Display Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 6292351
The global phage display market size was estimated at USD 933.2 million in 2025 and is projected to grow from USD 1.03 billion in 2026 to USD 2.08 billion by 2033, growing at a CAGR of 10.6% from 2026 to 2033. Market growth is driven by increasing demand for therapeutic antibodies, rising investments in biologics and drug discovery, and the expanding application of phage display technology in antibody engineering, target identification, and the development of novel therapeutics. Advancements in high-throughput screening and the growing adoption of phage display platforms for identifying high-affinity binding molecules are further supporting market expansion.

Industry Concentration & Characteristics

The phage display industry is characterized by a high degree of innovation, driven by continuous advances in antibody library design, screening techniques, and computational analysis to improve antibody diversity and affinity, and to enhance developability. For instance, in July 2024, Twist Bioscience announced that an antibody candidate discovered using its synthetic antibody phage display libraries had entered an exploratory Phase 0 clinical study, demonstrating the technology’s application in therapeutic antibody discovery.
The phage display industry is experiencing moderate M&A activity, with strategic transactions aimed at expanding antibody discovery capabilities and strengthening access to proprietary technologies. These arrangements enable companies to integrate specialized antibody libraries and optimization tools into their research workflows, supporting therapeutic antibody development. For instance, in March 2023, Specifica entered into an agreement with Servier and its subsidiary, Symphogen, to transfer its Generation 3 antibody libraries and associated optimization tools, thereby expanding access to advanced antibody discovery technologies.

“We are excited to enhance our antibody discovery capabilities by on-boarding Specifica’s Generation 3 phage display platform. The Specifica’s advanced platform will contribute to the development of drugs in particular in oncology, neuroscience and immune-inflammation which are among Servier’s foremost priorities.”
  • Christophe Thurieau, Global head of Research at Servier
The phage display industry is indirectly influenced by regulatory requirements governing therapeutic antibody development, including product characterization, safety assessment, potency testing, and manufacturing quality. These requirements encourage companies to implement robust validation processes and analytical testing to ensure the quality and consistency of antibody candidates identified through phage display technology.

The phage display industry is experiencing rapid expansion, supported by customized antibody libraries, screening platforms, and integrated antibody optimization services that address diverse therapeutic discovery needs. These solutions enable researchers to identify target-specific antibodies and improve their binding properties for downstream development. For instance, in April 2024, Fusion Antibodies secured its first commercial contract to develop a customized OptiPhage library, supporting the expansion of its antibody discovery portfolio and its ability to provide tailored solutions for therapeutic research.

The phage display industry is experiencing moderate to high regional expansion, as biotechnology companies and research institutions increase investment in antibody discovery capabilities across key markets. Growing collaborations among pharmaceutical companies, biotechnology firms, and specialized service providers are improving access to phage display platforms, supporting research, and expanding the availability of antibody discovery services across regions.

Global Phage Display Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, the analyst has segmented the global phage display market on the basis of product & service (with libraries further segmented by library type and library source), application, end use, and region

Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

  • Services
  • Kits & Reagents
  • Libraries

Libraries, by Library Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Antibody Libraries (scFv, Fab)
  • Peptide Libraries
  • Nanobody (VHH) Libraries
  • Others

Libraries, by Library Source Outlook (Revenue, USD Million, 2021 - 2033)

  • Synthetic & Semi-synthetic Libraries
  • Naive Libraries
  • Immune Libraries

Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Antibody Discovery & Development
  • Peptide & Small Protein Discovery
  • Protein Engineering
  • Vaccine Development & Epitope Mapping
  • Diagnostics
  • Others

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CDMOs
  • Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product & Service Segment
1.1.1.2. Library Type Segment
1.1.1.3. Library Source Segment
1.1.1.4. Application Segment
1.1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. The internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. List of Secondary Sources
1.9.3. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Demand for Therapeutic Antibodies
3.2.1.2. Advancements in High-Throughput Screening Technologies
3.2.1.3. Increasing Adoption of Phage Display in Antibody Engineering
3.2.2. Market Restraint Analysis
3.2.2.1. Limitations in Antibody Expression and Stability
3.2.2.2. High Cost of Phage Display Workflows
3.2.3. Market Opportunities Analysis
3.2.4. Market Challenges Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Social landscape
3.3.2.4. Economic landscape
3.3.2.5. Legal landscape
Chapter 4. Product & Service Business Analysis
4.1. Segment Dashboard
4.2. Phage Display Market: Product & Service Movement Analysis
4.3. Services
4.3.1. Services Market, 2021 - 2033 (USD Million)
4.4. Kits & Reagents
4.4.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
4.5. Libraries
4.5.1. Libraries Market, 2021 - 2033 (USD Million)
Chapter 5. Libraries: Library Type Business Analysis
5.1. Segment Dashboard
5.2. Phage Display Libraries Market: Library Type Movement Analysis
5.3. Antibody Libraries (scFv, Fab)
5.3.1. Antibody Libraries (scFv, Fab) Market, 2021 - 2033 (USD Million)
5.4. Peptide Libraries
5.4.1. Peptide Libraries Market, 2021 - 2033 (USD Million)
5.5. Nanobody (VHH) Libraries
5.5.1. Nanobody (VHH) Libraries Market, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Libraries: Library Source Business Analysis
6.1. Segment Dashboard
6.2. Phage Display Libraries Market: Library Source Movement Analysis
6.3. Synthetic & Semi-synthetic Libraries
6.3.1. Synthetic & Semi-synthetic Libraries Market, 2021 - 2033 (USD Million)
6.4. Naive Libraries
6.4.1. Naive Libraries Market, 2021 - 2033 (USD Million)
6.5. Immune Libraries
6.5.1. Immune Libraries Market, 2021 - 2033 (USD Million)
Chapter 7. Application Business Analysis
7.1. Segment Dashboard
7.2. Phage Display Market: Application Movement Analysis
7.3. Antibody Discovery & Development
7.3.1. Antibody Discovery & Development Market, 2021 - 2033 (USD Million)
7.4. Peptide & Small Protein Discovery
7.4.1. Peptide & Small Protein Discovery Market, 2021 - 2033 (USD Million)
7.5. Protein Engineering
7.5.1. Protein Engineering Market, 2021 - 2033 (USD Million)
7.6. Vaccine Development & Epitope Mapping
7.6.1. Vaccine Development & Epitope Mapping Market, 2021 - 2033 (USD Million)
7.7. Diagnostics
7.7.1. Diagnostics Market, 2021 - 2033 (USD Million)
7.8. Others
7.8.1. Others Market, 2021 - 2033 (USD Million)
Chapter 8. End Use Business Analysis
8.1. Segment Dashboard
8.2. Phage Display Market: End Use Movement Analysis
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
8.4. Academic & Research Institutes
8.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
8.5. CROs & CDMOs
8.5.1. CROs & CDMOs Market, 2021 - 2033 (USD Million)
8.6. Others
8.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Phage Display Market Share by Region, 2025 & 2033
9.2. North America
9.2.1. North America Phage Display Market, 2021 - 2033 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Competitive Scenario
9.2.2.3. Regulatory Framework
9.2.2.4. U.S. Phage Display Market, 2021 - 2033 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Competitive Scenario
9.2.3.3. Regulatory Framework
9.2.3.4. Canada Phage Display Market, 2021 - 2033 (USD Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Competitive Scenario
9.2.4.3. Regulatory Framework
9.2.4.4. Mexico Phage Display Market, 2021 - 2033 (USD Million)
9.3. Europe
9.3.1. Europe Phage Display Market, 2021 - 2033 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Regulatory Framework
9.3.2.4. UK Phage Display Market, 2021 - 2033 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. Germany Phage Display Market, 2021 - 2033 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. France Phage Display Market, 2021 - 2033 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Competitive Scenario
9.3.5.3. Regulatory Framework
9.3.5.4. Italy Phage Display Market, 2021 - 2033 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Competitive Scenario
9.3.6.3. Regulatory Framework
9.3.6.4. Spain Phage Display Market, 2021 - 2033 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Competitive Scenario
9.3.7.3. Regulatory Framework
9.3.7.4. Denmark Phage Display Market, 2021 - 2033 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Competitive Scenario
9.3.8.3. Regulatory Framework
9.3.8.4. Sweden Phage Display Market, 2021 - 2033 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Competitive Scenario
9.3.9.3. Regulatory Framework
9.3.9.4. Norway Phage Display Market, 2021 - 2033 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Phage Display Market, 2021 - 2033 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. Japan Phage Display Market, 2021 - 2033 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. China Phage Display Market, 2021 - 2033 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. India Phage Display Market, 2021 - 2033 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. Australia Phage Display Market, 2021 - 2033 (USD Million)
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Thailand Phage Display Market, 2021 - 2033 (USD Million)
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. South Korea Phage Display Market, 2021 - 2033 (USD Million)
9.5. Latin America
9.5.1. Latin America Phage Display Market, 2021 - 2033 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Brazil Phage Display Market, 2021 - 2033 (USD Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. Argentina Phage Display Market, 2021 - 2033 (USD Million)
9.6. MEA
9.6.1. MEA Phage Display Market, 2021 - 2033 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. South Africa Phage Display Market, 2021 - 2033 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Saudi Arabia Phage Display Market, 2021 - 2033 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Competitive Scenario
9.6.4.3. Regulatory Framework
9.6.4.4. UAE Phage Display Market, 2021 - 2033 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Competitive Scenario
9.6.5.3. Regulatory Framework
9.6.5.4. Kuwait Phage Display Market, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Company Market Share/ Position Analysis, 2025
10.3. Strategy Mapping
10.4. Company Profiles/Listing
10.4.1. Bio-Rad Laboratories, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Twist Bioscience
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. GenScript
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. FairJourney Bio
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. New England Biolabs
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Creative Biolabs
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. ProteoGenix
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Sino Biological, Inc.
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Bicycle Therapeutics
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Fusion Antibodies
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
10.4.11. Charles River Laboratories
10.4.11.1. Overview
10.4.11.2. Financial Performance
10.4.11.3. Product Benchmarking
10.4.11.4. Strategic Initiatives
10.4.12. IRBM
10.4.12.1. Overview
10.4.12.2. Financial Performance
10.4.12.3. Product Benchmarking
10.4.12.4. Strategic Initiatives
10.4.13. Aragen Life Sciences Ltd.
10.4.13.1. Overview
10.4.13.2. Financial Performance
10.4.13.3. Product Benchmarking
10.4.13.4. Strategic Initiatives
10.4.14. Antibody Design Labs
10.4.14.1. Overview
10.4.14.2. Financial Performance
10.4.14.3. Product Benchmarking
10.4.14.4. Strategic Initiatives
10.4.15. Cell Origins LLC
10.4.15.1. Overview
10.4.15.2. Financial Performance
10.4.15.3. Product Benchmarking
10.4.15.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global phage display market, product & service, 2021 - 2033 (USD Million)
Table 4 Global phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 5 Global phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 6 Global phage display market, application, 2021 - 2033 (USD Million)
Table 7 Global phage display market, end use, 2021 - 2033 (USD Million)
Table 8 Global phage display market, region, 2021 - 2033 (USD Million)
Table 9 North America phage display market, country, 2021 - 2033 (USD Million)
Table 10 North America phage display market, product & service, 2021 - 2033 (USD Million)
Table 11 North America phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 12 North America phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 13 North America phage display market, application, 2021 - 2033 (USD Million)
Table 14 North America phage display market, end use, 2021 - 2033 (USD Million)
Table 15 U.S. phage display market, product & service, 2021 - 2033 (USD Million)
Table 16 U.S. phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 17 U.S. phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 18 U.S. phage display market, application, 2021 - 2033 (USD Million)
Table 19 U.S. phage display market, end use, 2021 - 2033 (USD Million)
Table 20 Canada phage display market, product & service, 2021 - 2033 (USD Million)
Table 21 Canada phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 22 Canada phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 23 Canada phage display market, application, 2021 - 2033 (USD Million)
Table 24 Canada phage display market, end use, 2021 - 2033 (USD Million)
Table 25 Mexico phage display market, product & service, 2021 - 2033 (USD Million)
Table 26 Mexico phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 27 Mexico phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 28 Mexico phage display market, application, 2021 - 2033 (USD Million)
Table 29 Mexico phage display market, end use, 2021 - 2033 (USD Million)
Table 30 Europe phage display market, country, 2021 - 2033 (USD Million)
Table 31 Europe phage display market, product & service, 2021 - 2033 (USD Million)
Table 32 Europe phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 33 Europe phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 34 Europe phage display market, application, 2021 - 2033 (USD Million)
Table 35 Europe phage display market, end use, 2021 - 2033 (USD Million)
Table 36 UK phage display market, product & service, 2021 - 2033 (USD Million)
Table 37 UK phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 38 UK phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 39 UK phage display market, application, 2021 - 2033 (USD Million)
Table 40 UK phage display market, end use, 2021 - 2033 (USD Million)
Table 41 Germany phage display market, product & service, 2021 - 2033 (USD Million)
Table 42 Germany phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 43 Germany phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 44 Germany phage display market, application, 2021 - 2033 (USD Million)
Table 45 Germany phage display market, end use, 2021 - 2033 (USD Million)
Table 46 France phage display market, product & service, 2021 - 2033 (USD Million)
Table 47 France phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 48 France phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 49 France phage display market, application, 2021 - 2033 (USD Million)
Table 50 France phage display market, end use, 2021 - 2033 (USD Million)
Table 51 Italy phage display market, product & service, 2021 - 2033 (USD Million)
Table 52 Italy phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 53 Italy phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 54 Italy phage display market, application, 2021 - 2033 (USD Million)
Table 55 Italy phage display market, end use, 2021 - 2033 (USD Million)
Table 56 Spain phage display market, product & service, 2021 - 2033 (USD Million)
Table 57 Spain phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 58 Spain phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 59 Spain phage display market, application, 2021 - 2033 (USD Million)
Table 60 Spain phage display market, end use, 2021 - 2033 (USD Million)
Table 61 Denmark phage display market, product & service, 2021 - 2033 (USD Million)
Table 62 Denmark phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 63 Denmark phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 64 Denmark phage display market, application, 2021 - 2033 (USD Million)
Table 65 Denmark phage display market, end use, 2021 - 2033 (USD Million)
Table 66 Sweden phage display market, product & service, 2021 - 2033 (USD Million)
Table 67 Sweden phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 68 Sweden phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 69 Sweden phage display market, application, 2021 - 2033 (USD Million)
Table 70 Sweden phage display market, end use, 2021 - 2033 (USD Million)
Table 71 Norway phage display market, product & service, 2021 - 2033 (USD Million)
Table 72 Norway phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 73 Norway phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 74 Norway phage display market, application, 2021 - 2033 (USD Million)
Table 75 Norway phage display market, end use, 2021 - 2033 (USD Million)
Table 76 Asia Pacific phage display market, country, 2021 - 2033 (USD Million)
Table 77 Asia Pacific phage display market, product & service, 2021 - 2033 (USD Million)
Table 78 Asia Pacific phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 79 Asia Pacific phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 80 Asia Pacific phage display market, application, 2021 - 2033 (USD Million)
Table 81 Asia Pacific phage display market, end use, 2021 - 2033 (USD Million)
Table 82 Japan phage display market, product & service, 2021 - 2033 (USD Million)
Table 83 Japan phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 84 Japan phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 85 Japan phage display market, application, 2021 - 2033 (USD Million)
Table 86 Japan phage display market, end use, 2021 - 2033 (USD Million)
Table 87 China phage display market, product & service, 2021 - 2033 (USD Million)
Table 88 China phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 89 China phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 90 China phage display market, application, 2021 - 2033 (USD Million)
Table 91 China phage display market, end use, 2021 - 2033 (USD Million)
Table 92 India phage display market, product & service, 2021 - 2033 (USD Million)
Table 93 India phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 94 India phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 95 India phage display market, application, 2021 - 2033 (USD Million)
Table 96 India phage display market, end use, 2021 - 2033 (USD Million)
Table 97 Australia phage display market, product & service, 2021 - 2033 (USD Million)
Table 98 Australia phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 99 Australia phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 100 Australia phage display market, application, 2021 - 2033 (USD Million)
Table 101 Australia phage display market, end use, 2021 - 2033 (USD Million)
Table 102 Thailand phage display market, product & service, 2021 - 2033 (USD Million)
Table 103 Thailand phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 104 Thailand phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 105 Thailand phage display market, application, 2021 - 2033 (USD Million)
Table 106 Thailand phage display market, end use, 2021 - 2033 (USD Million)
Table 107 South Korea phage display market, product & service, 2021 - 2033 (USD Million)
Table 108 South Korea phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 109 South Korea phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 110 South Korea phage display market, application, 2021 - 2033 (USD Million)
Table 111 South Korea phage display market, end use, 2021 - 2033 (USD Million)
Table 112 Latin America phage display market, country, 2021 - 2033 (USD Million)
Table 113 Latin America phage display market, product & service, 2021 - 2033 (USD Million)
Table 114 Latin America phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 115 Latin America phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 116 Latin America phage display market, application, 2021 - 2033 (USD Million)
Table 117 Latin America phage display market, end use, 2021 - 2033 (USD Million)
Table 118 Brazil phage display market, product & service, 2021 - 2033 (USD Million)
Table 119 Brazil phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 120 Brazil phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 121 Brazil phage display market, application, 2021 - 2033 (USD Million)
Table 122 Brazil phage display market, end use, 2021 - 2033 (USD Million)
Table 123 Argentina phage display market, product & service, 2021 - 2033 (USD Million)
Table 124 Argentina phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 125 Argentina phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 126 Argentina phage display market, application, 2021 - 2033 (USD Million)
Table 127 Argentina phage display market, end use, 2021 - 2033 (USD Million)
Table 128 Middle East & Africa phage display market, country, 2021 - 2033 (USD Million)
Table 129 Middle East & Africa phage display market, product & service, 2021 - 2033 (USD Million)
Table 130 Middle East & Africa phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 131 Middle East & Africa phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 132 Middle East & Africa phage display market, application, 2021 - 2033 (USD Million)
Table 133 Middle East & Africa phage display market, end use, 2021 - 2033 (USD Million)
Table 134 South Africa phage display market, product & service, 2021 - 2033 (USD Million)
Table 135 South Africa phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 136 South Africa phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 137 South Africa phage display market, application, 2021 - 2033 (USD Million)
Table 138 South Africa phage display market, end use, 2021 - 2033 (USD Million)
Table 139 Saudi Arabia phage display market, product & service, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 142 Saudi Arabia phage display market, application, 2021 - 2033 (USD Million)
Table 143 Saudi Arabia phage display market, end use, 2021 - 2033 (USD Million)
Table 144 UAE phage display market, product & service, 2021 - 2033 (USD Million)
Table 145 UAE phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 146 UAE phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 147 UAE phage display market, application, 2021 - 2033 (USD Million)
Table 148 UAE phage display market, end use, 2021 - 2033 (USD Million)
Table 149 Kuwait phage display market, product & service, 2021 - 2033 (USD Million)
Table 150 Kuwait phage display libraries market, library type, 2021 - 2033 (USD Million)
Table 151 Kuwait phage display libraries market, library source, 2021 - 2033 (USD Million)
Table 152 Kuwait phage display market, application, 2021 - 2033 (USD Million)
Table 153 Kuwait phage display market, end use, 2021 - 2033 (USD Million)
List of Figures
Figure 1 Phage display market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Phage display market driver analysis
Figure 12 Phage display market restraint analysis
Figure 13 Phage display market: Porter's five forces analysis
Figure 14 Phage display market: PESTLE analysis
Figure 15 Phage display market: product & service outlook and key takeaways
Figure 16 Phage display market: product & service market share analysis
Figure 17 Services market, 2021 - 2033 (USD Million)
Figure 18 Kits & reagents market, 2021 - 2033 (USD Million)
Figure 19 Libraries market, 2021 - 2033 (USD Million)
Figure 20 Phage display libraries market: library type outlook and key takeaways
Figure 21 Phage display libraries market: library type market share analysis
Figure 22 Antibody libraries (scFv, Fab) market, 2021 - 2033 (USD Million)
Figure 23 Peptide libraries market, 2021 - 2033 (USD Million)
Figure 24 Nanobody (VHH) libraries market, 2021 - 2033 (USD Million)
Figure 25 Others market, 2021 - 2033 (USD Million)
Figure 26 Phage display libraries market: library source outlook and key takeaways
Figure 27 Phage display libraries market: library source market share analysis
Figure 28 Synthetic & semi-synthetic libraries market, 2021 - 2033 (USD Million)
Figure 29 Naive libraries market, 2021 - 2033 (USD Million)
Figure 30 Immune libraries market, 2021 - 2033 (USD Million)
Figure 31 Phage display market: application outlook and key takeaways
Figure 32 Phage display market: application market share analysis
Figure 33 Antibody discovery & development market, 2021 - 2033 (USD Million)
Figure 34 Peptide & small protein discovery market, 2021 - 2033 (USD Million)
Figure 35 Protein engineering market, 2021 - 2033 (USD Million)
Figure 36 Vaccine development & epitope mapping market, 2021 - 2033 (USD Million)
Figure 37 Diagnostics market, 2021 - 2033 (USD Million)
Figure 38 Others market, 2021 - 2033 (USD Million)
Figure 39 Phage display market: end use outlook and key takeaways
Figure 40 Phage display market: end use market share analysis
Figure 41 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Figure 42 Academic & research institutes market, 2021 - 2033 (USD Million)
Figure 43 CROs & CDMOs market, 2021 - 2033 (USD Million)
Figure 44 Others market, 2021 - 2033 (USD Million)
Figure 45 Regional marketplace: Key takeaways
Figure 46 North America phage display market, country, 2021 - 2033 (USD Million)
Figure 47 U.S. phage display market, 2021 - 2033 (USD Million)
Figure 48 Canada phage display market, 2021 - 2033 (USD Million)
Figure 49 Mexico phage display market, 2021 - 2033 (USD Million)
Figure 50 Europe phage display market, country, 2021 - 2033 (USD Million)
Figure 51 UK phage display market, 2021 - 2033 (USD Million)
Figure 52 Germany phage display market, 2021 - 2033 (USD Million)
Figure 53 France phage display market, 2021 - 2033 (USD Million)
Figure 54 Italy phage display market, 2021 - 2033 (USD Million)
Figure 55 Spain phage display market, 2021 - 2033 (USD Million)
Figure 56 Denmark phage display market, 2021 - 2033 (USD Million)
Figure 57 Sweden phage display market, 2021 - 2033 (USD Million)
Figure 58 Norway phage display market, 2021 - 2033 (USD Million)
Figure 59 Asia-Pacific phage display market, country, 2021 - 2033 (USD Million)
Figure 60 Japan phage display market, 2021 - 2033 (USD Million)
Figure 61 China phage display market, 2021 - 2033 (USD Million)
Figure 62 India phage display market, 2021 - 2033 (USD Million)
Figure 63 Australia phage display market, 2021 - 2033 (USD Million)
Figure 64 Thailand phage display market, 2021 - 2033 (USD Million)
Figure 65 South Korea phage display market, 2021 - 2033 (USD Million)
Figure 66 Latin America phage display market, country, 2021 - 2033 (USD Million)
Figure 67 Brazil phage display market, 2021 - 2033 (USD Million)
Figure 68 Argentina phage display market, 2021 - 2033 (USD Million)
Figure 69 MEA phage display market, country, 2021 - 2033 (USD Million)
Figure 70 South Africa phage display market, 2021 - 2033 (USD Million)
Figure 71 Saudi Arabia phage display market, 2021 - 2033 (USD Million)
Figure 72 UAE phage display market, 2021 - 2033 (USD Million)
Figure 73 Kuwait phage display market, 2021 - 2033 (USD Million)

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • Twist Bioscience
  • GenScript
  • FairJourney Bio
  • New England Biolabs
  • Creative Biolabs
  • ProteoGenix
  • Sino Biological, Inc.
  • Bicycle Therapeutics
  • Fusion Antibodies
  • Charles River Laboratories
  • IRBM
  • Aragen Life Sciences Ltd.
  • Antibody Design Labs
  • Cell Origins LLC